To the full analysis
Surgical Science Sweden stock: growth
SUS.STSurgical Science Sweden reported $99.5M in revenue for fiscal 2025, up 12.2% on the prior year.
Revenue (Annual rate)
33.6%
per year from 2014 to 2025, per share 19%
Earnings (Annual rate)
no data
Free cash flow (Annual rate)
no data
Growth per year by period
What reaches shareholders is growth per share: buybacks lift it, new shares dilute it.
| since 2020 | since 2015 | since 2014 | |
|---|---|---|---|
| Revenue | 56.8% | 35.9% | 33.6% |
| Revenue per share | 44.9% | 26.2% | 19.0% |
| Earnings | 33.8% | 45.2% | no data |
| Earnings per share | 23.8% | 34.9% | no data |
| Free cash flow | 36.2% | no data | no data |
| Free cash flow per share | 25.9% | no data | no data |
Fiscal years at a glance
How revenue and earnings grow
- Revenue
- Earnings
- Free cash flow
Figures as a table
| Year | Revenue | Earnings | Free cash flow |
|---|---|---|---|
| 2014 | $4.12M | −$304.51K | $0 |
| 2015 | $4.62M | $160.43K | −$80.22K |
| 2016 | $5.19M | $330.9K | $170.46K |
| 2017 | $5.81M | −$226.41K | −$419.03K |
| 2018 | $6.59M | −$453.13K | −$176.38K |
| 2019 | $10.18M | $1.26M | $4.64M |
| 2020 | $10.51M | $1.56M | $1.46M |
| 2021 | $36.78M | $8.65M | $2.48M |
| 2022 | $80.47M | $18.85M | $9.52M |
| 2023 | $88.52M | $23.46M | $19.47M |
| 2024 | $88.65M | $13.2M | $8.99M |
| 2025 | $99.5M | $6.7M | $6.83M |
Data status and sources
- Price
- Closing price of 12 Nov 2026
- Latest annual report
- Fiscal year 2025, period end 31 Dec 2025
- Currency
- Amounts in US dollars, converted at the ECB reference rate of 12 Nov 2026 ($1 = SEK 9.9729)
- Source
- Financial statements, ratios and prices from Financial Modeling Prep (FMP), based on the company's reports. MEQIRI calculates the score and fair value from them.
Mandatory disclosures for this rating
- ; time horizon around 12 months
- Rated Neutral, published since 7 Nov 2026 (in the score history since 3 Apr 2026)
- Valuation signal Undervalued since 13 Nov 2026, previously Fairly valued
- End-of-day prices, metrics cached for up to 24 hours
- Score and fair value are estimates from a disclosed model. They are not facts and not a price target.
- Produced by SSM Ventures UG (haftungsbeschränkt), responsible person Sven Brostmeyer, Managing Director, automatically according to the disclosed model.
- Not investment advice. Losses up to and including a total loss are possible. Personal circumstances are not considered.